⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL254738 | 1.00 | — | — | |
| SCHEMBL223813 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL20299896 | 0.97 | ALDH1A1 (0.56) | — | |
| Hydrochloric Acid SCHEMBL20299895 | 0.97 | ALDH1A1 (0.56) | — | |
| Nitrous Acid SCHEMBL1414648 | 0.90 | ALDH1A1 (0.50) | — | |
| SCHEMBL8673266 | 0.82 | — | — | |
| SCHEMBL27548159 | 0.82 | — | — | |
| SCHEMBL6433 | 0.79 | — | — | |
| SCHEMBL6672007 | 0.79 | ALDH1A1 (0.62) | — | |
| SCHEMBL7396758 | 0.79 | ALDH1A1 (0.62) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117802803-B | Low-temperature printing and dyeing method for cloth and printing and dyeing fixation additive thereof | 平南启源纺织有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-117802803-A | Low-temperature printing and dyeing method for cloth and printing and dyeing fixation additive thereof | 平南启源纺织有限公司 | 2024-04-02 | — | — | CN | claimed |
| EP-4267590-A1 | ARGINASE INHIBITORS AND METHODS OF USE THEREOF | ONCOARENDI THERAPEUTICS S.A. (PL) | 2023-11-01 | — | — | EP | claimed |
| WO-2022137156-A1 | ARGINASE INHIBITORS AND METHODS OF USE THEREOF | Oncoarendi Therapeutics S.A. (PL) | 2022-06-30 | — | — | WO | claimed |
| US-20220204530-A1 | ARGINASE INHIBITORS AND METHODS OF USE THEREOF | MOLECURE S.A. (PL) | 2022-06-30 | — | — | US | claimed |
| EP-2802627-B1 | PARTICULATE SOLID, PROCESS FOR THE PRODUCTION THEREOF, USE AS FILLER AND ASSOCIATED ARTICLES | EVONIK DEGUSSA GMBH (DE) | 2018-05-23 | — | — | EP | claimed |
| EP-2217063-B1 | THIOLATED PACLITAXELS FOR REACTION WITH GOLD NANOPARTICLES AS DRUG DELIVERY AGENTS | VIRGINIA TECH INTELL PROP (US) | 2014-12-17 | — | — | EP | claimed |
| US-7442683-B2 | Cyclic peptide | TAKARA BIO INC. (JP) | 2008-10-28 | — | — | US | claimed |
| EP-0739882-B1 | Novel aconitine compounds and analgesic/anti-inflammatory agent containing the same | SANWA SHOYAKU KK (JP) | 2001-06-13 | — | — | EP | claimed |
| EP-3478311-B1 | STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION | UNIV CALIFORNIA (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12612420-B2 | Arginase inhibitors and methods of use thereof | MOLECURE S.A. (PL) | 2026-04-28 | — | — | US | disclosed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| EP-3596102-B1 | STRUCTURE-BASED PEPTIDE INHIBITORS THAT TARGET THE TAU VQIINK FIBRILLIZATION SEGMENT | UNIV CALIFORNIA (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20250197360-A1 | NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE | BARUCH S. BLUMBERG INSTITUTE | 2025-06-19 | — | — | US | disclosed |
| WO-2000009492-A1 | TACE INHIBITORS | PFIZER PRODUCTS INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| EP-0973748-A1 | METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES | AGOURON PHARMACEUTICALS, INC. (US) | 2000-01-26 | — | — | EP | disclosed |
| US-5985900-A | TREATING TUMOR GROWTH, INVASION OR METASTASIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CHRONIC DERMAL WOUNDS, CORNEAL ULCERATION, DEGENERATIVE SKIN DISORDERS, MULTIPLE SCLEROSIS, STROKE, ATHEROSCLEROSIS, | AGOURON PHARMACEUTICALS, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1998043963-A1 | METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES | AGOURON PHARMACEUTICALS, INC. (US) | 1998-10-08 | — | — | WO | disclosed |
| EP-0385172-A1 | Process for transformation of hydroxyketo acids to hydroxyamino acids | E.R. SQUIBB & SONS, INC. (US) | 1990-09-05 | — | — | EP | disclosed |
| EP-0199661-A1 | Process for the preparation of acylbiphenyl derivatives | RHONE-POULENC CHIMIE (FR) | 1986-10-29 | — | — | EP | disclosed |